Skip to main content
Andrew Kung, MD, Pediatric Hematology & Oncology, New York, NY

AndrewL.KungMDPhD

Pediatric Hematology & Oncology • New York, NY

Chair, Department of Pediatrics, Memorial Sloan Kettering Cancer Center

Request Appointment

Overview of Dr. Kung

Dr. Andrew Kung is a pediatric hematologist/oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Stanford University School of Medicine and has been in practice 23 years. Dr. Kung accepts several types of health insurance, listed below. He is one of 135 doctors at New York-Presbyterian Hospital and one of 37 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Pediatric Hematology & Oncology. He has more than 100 publications and over 500 citings.

Education & Training

  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1996 - 1999
  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1994 - 1996
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 1994

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2013 - 2026
  • MA State Medical License
    MA State Medical License 1996 - 2013
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2010
  • Elected Member Society for Pediatric Research

Publications & Presentations

PubMed

Journal Articles

  • Important Concerns over SARS-CoV-2 Infection in Children with Cancer—Reply  
    Andrew L Kung, Farid Boulad, JAMA Oncology
  • COVID-19 in Children with Cancer in New York City  
    Farid Boulad, Mini Kamboj, Andrew L Kung, JAMA Oncology
  • BRCA1-IRIS Promotes Human Tumor Progression Through PTEN Blockade and HIF-1α Activation  
    David M Livingston, Kimberly J Briggs, Andrew L Kung, Proceedings of the National Academy of Sciences

Authored Content

  • COVID-19 in Children with Cancer in New York CityMay 2020

Press Mentions

  • To Save Children with Cancer, Doctors Turn to New Weapons
    To Save Children with Cancer, Doctors Turn to New WeaponsAugust 5th, 2022
  • Experiences from the Epicenter: Professional Impact of the COVID‐19 Pandemic on Genetic Counselors in New York
    Experiences from the Epicenter: Professional Impact of the COVID‐19 Pandemic on Genetic Counselors in New YorkNovember 23rd, 2020
  • How Genomics Can Improve Cancer Care (At Techonomy Health)
    How Genomics Can Improve Cancer Care (At Techonomy Health)June 14th, 2017
  • Join now to see all

Grant Support

  • Targeting The ETS Transcription Factor Rearrangement EWS/FLI In Ewing'S SarcomaNational Institute On Drug Abuse2012
  • Functionizing The Epigenome In Ewing SarcomaNational Cancer Institute2012
  • Transcription Factor And Epigenetic Regulation Of Hypoxic Gene ExpressionNational Institute Of General Medical Sciences2008–2012
  • A Novel Probe For Imaging ApoptosisNational Institute Of Biomedical Imaging And Bioengineering2010–2011
  • Hypoxia Inducible Transcription In Antitumor StrategiesNational Cancer Institute2001–2005

Professional Memberships

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS Massachusetts Blue Care Elect PPO
    First Health PPO
    Great West PPO
    Harvard Pilgrim HMO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    Tufts Health Plan PPO
    UniCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. Andrew Kung, Dr. Andrew Kung, MD, Dr. A Kung, Dr. Andrew L. Kung